Vaccinations

Why immunisation matters for healthy ageing

ILC is the UK’s leading authority on the impact of longevity on society, combining evidence, solutions and networks to make change happen. We hear...

MPs say UK Test and Trace system “ultimately failed” to stop deaths

The 150-page Health and Social Committee report says the UK Government "ultimately failed" to establish a working Test and Trace system - which led to thousands of COVID deaths.

First malaria vaccine offers “glimmer of hope” to millions

The World Health Organisation has recently authorised a malaria vaccine, RTS,S/AS01, which has been successful in pilot schemes launched in 2019.

Merck “COVID pill” sold at forty-times what it costs to make

The "COVID pill" by Merck, found to halve virus hospitalisation and death rates, will be sold in the US at $712 per treatment - while costing $17.74 to produce.

The COVID insight of Molecular and Cellular Biosciences

We reflect on the work of the Molecular and Cellular Biosciences division (MCB), especially in context of the “complex biological web” of a global pandemic.

Study finds Pfizer vaccine works at 90% efficacy for six months

The study, published in The Lancet, finds that two doses of the Pfizer vaccine are 90% efficient for six months - decreasing to 47% after that time period.

Scientists create experimental vaccine for rheumatoid arthritis

The scientists found that "rheumatoid arthritis totally disappeared" in animals that were given the vaccine - creating hope for a functional vaccine.

Study says 0.0006% chance of myocarditis as COVID vaccine side effect

According to a study with 2,392,924 participants, acute myocarditis is an extremely rare side effect of the COVID vaccine - at 0.0006% likelihood.

Merck says “COVID pill” can decrease risk of death by 50%

Pharmaceutical company, Merck, have a "COVID pill" at Phase 3 clinical trial - which seems to decrease risk of death by 50%.

WHO recommends antibody treatment for immunocompromised people

The World Health Organisation, based on a study in The BMJ, finds that combining two antibody treatments could help immunocompromised people.

South Africa: An ongoing battle with HIV

With 7.5 million people living with HIV, how has climate change and COVID-19 affected the South African governments control over the AIDS crisis and which demographics have been hit the hardest?

NIH funds menstrual cycle and COVID vaccine research

McLean Hospital’s Clinical and Translational Pain Research Laboratory is one of five institutions splitting a $1.67 million NIH grant - the research will examine any links between the menstrual cycle and the COVID vaccine.

FDA approves Pfizer booster vaccine for over 65s

The U.S. Food and Drug Administration (FDA) has given authorisation for the Pfizer/BioNTech COVID-19 booster vaccine to be administered to people aged 65 and over.

UK approves COVID vaccination for 12-15 year olds

The UK's Chief Medical Officers have approved COVID vaccination for young people aged between 12-15 years old, to begin by 22 September, 2021.

COVID-19 vaccines: Risks versus benefits

Lauren Matelski, Jeremy MacMahon, and Pamela J. Lein from the University of California, Davis, weigh the risks associated with COVID-19 vaccines versus the benefits.

Report documents 17% higher rate of COVID death in North England

The Northern Health Science Alliance report says the North of England experienced a 17% higher rate of COVID death than the South - because of "higher deprivation and worse pre-pandemic health".

UK approves Pfizer and AstraZeneca for third COVID dose

The UK medicine regulator approved both Pfizer and AstraZeneca vaccines as a third COVID dose - for use in a new UK booster scheme.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders